Ironwood Pharmaceuticals
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 267
- Market Cap
- $782.7M
- Introduction
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)
- Conditions
- Interventions
- First Posted Date
- 2015-12-22
- Last Posted Date
- 2019-10-15
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 282
- Registration Number
- NCT02637557
- Locations
- 🇺🇸
IW-3718 Investigator, Lynchburg, Virginia, United States
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
- Conditions
- Interventions
- First Posted Date
- 2015-09-24
- Last Posted Date
- 2020-04-24
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 759
- Registration Number
- NCT02559206
- Locations
- 🇺🇸
Ironwood Investigational Site, La Crosse, Wisconsin, United States
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
- Conditions
- Interventions
- First Posted Date
- 2014-11-14
- Last Posted Date
- 2017-06-15
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 1223
- Registration Number
- NCT02291679
- Locations
- 🇺🇸
Ironwood Investigational Site, La Crosse, Wisconsin, United States
Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)
- First Posted Date
- 2014-11-13
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT02289846
- Locations
- 🇺🇸
Ironwood Investigational Site, Ogden, Utah, United States
Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors
- First Posted Date
- 2014-01-09
- Last Posted Date
- 2016-08-01
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 93
- Registration Number
- NCT02030925
- Locations
- 🇺🇸
Ironwood Investigational Site, South Ogden, Utah, United States
Phase 2a Study of IW-9179 to Treat Functional Dyspepsia
- Conditions
- Interventions
- First Posted Date
- 2012-10-23
- Last Posted Date
- 2014-03-19
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT01712412
- Locations
- 🇳🇱
Andromed Leiden, Leiden, Netherlands
🇳🇱PreCare Trial and Recruitment, Beek, Netherlands
🇧🇪AZ Sint-Lucas Brugge, Brugge, Belgium
Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar Extraction
- Conditions
- Interventions
- First Posted Date
- 2010-04-20
- Last Posted Date
- 2022-08-11
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT01107236
- Locations
- 🇺🇸
Ironwood Investigational Site, Salt Lake City, Utah, United States
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
- Conditions
- Interventions
- First Posted Date
- 2009-07-14
- Last Posted Date
- 2013-11-05
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 805
- Registration Number
- NCT00938717
- Locations
- 🇺🇸
Ironwood Investigational Site, Milwaukee, Wisconsin, United States
Trial of Linaclotide in Patients With Chronic Constipation
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2013-01-30
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 643
- Registration Number
- NCT00730015
- Locations
- 🇺🇸
Ironwood Investigational Site, Milwaukee, Wisconsin, United States
An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
- Conditions
- Interventions
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2018-02-19
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 1743
- Registration Number
- NCT00730171
- Locations
- 🇺🇸
Ironwood Investigational Site, Milwaukee, Wisconsin, United States